e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
BAL neutrophilia as a predictor factor on IPF mortality
A. P. Vaz, A. Morais, M. C. Palmares, N. Melo, M. Beltrão, B. Lima, L. Delgado (Oporto, Portugal)
Source:
Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session:
Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
5236
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. P. Vaz, A. Morais, M. C. Palmares, N. Melo, M. Beltrão, B. Lima, L. Delgado (Oporto, Portugal). BAL neutrophilia as a predictor factor on IPF mortality. Eur Respir J 2010; 36: Suppl. 54, 5236
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Could airway basal cells be a novel predictor of mortality in IPF?
Source: Breathe, 15 (4) 343; 10.1183/20734735.0265-2019
Year: 2019
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
A family history of ILD is a significant risk factor for worse transplant-free survival in IPF patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Serum CC16 is a potential predictor for IPF diagnosis and prognosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Sputum cellularity and IL-8 levels are related to clinical and pulmonary function abnormalities in patients with asbestosis
Source: Eur Respir J 2006; 28: Suppl. 50, 692s
Year: 2006
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The risk of bronchoalveolar fluid (BAF) contamination in ICU patients with infectious pulmonary complications
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005
Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
KL-6 compared to LDH as a prognostic factor in Caucasian patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003
IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 465s
Year: 2004
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept